BIO vs PRSO · rev $2.58B vs rev $14.6M
BIO (BIO) versus Peraso Inc (PRSO) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Peraso Inc (PRSO) is a semiconductors company listed on NASDAQ.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
Latest reported PRSO revenue for 2024-12-31 was $14.6M. Net income was -$10.7M. Revenue was up 6.0% from 2023-12-31 to 2024-12-31. PRSO currently screens at market cap $13.1M.
BIO currently screens at market cap $0. PRSO currently screens at market cap $13.1M.
Not investment advice. Open the BIO and PRSO stock pages for the full models.
Not investment advice.